Skip navigation.

HOME > Publications > Proceedings of the Japan Academy, Ser. B, Physical and Biological Sciences

Proceedings of the Japan Academy, Ser. B, Physical and Biological Sciences

J-STAGE

Project Euclid

CiNii

PubMed Logo

The Proceedings of the Japan Academy, Series B was founded in 1912 as the Proceedings of the Imperial Academy by the then Imperial Academy of Japan (now the Japan Academy). The Journal was split to the Proceedings of the Japan Academy, Series A and Series B in 1977. PJA Series B publishes reviews and original articles in broad fields of natural sciences, such as chemistry, physics, astronomy, earth sciences, biology, engineering, agricultural sciences and medical sciences. All manuscripts are evaluated at least by two reviewers. Ten issues are published per year. The entire content is now freely available online through J-STAGE.

Vol. 90 No. 7 (2014)


Review
Frontal affinity chromatography: A unique research tool for biospecific interaction that promotes glycobiology
Kenichi KASAI
Proc. Jpn. Acad., Ser. B, Vol. 90, 215-234 (2014) [abstract] [PDF]
Control of synaptic function by endocannabinoid-mediated retrograde signaling
Masanobu KANO
Proc. Jpn. Acad., Ser. B, Vol. 90, 235-250 (2014) [abstract] [PDF]
Strategies for eliminating death from gastric cancer in Japan
Masahiro ASAKA, Katsuhiro MABE
Proc. Jpn. Acad., Ser. B, Vol. 90, 251-258 (2014) [abstract] [PDF]
Cover Illustration
Endocannabinoid as synaptic retrograde messenger that regulates neurotransmitter release
 

Marijuana, a derivative of the plant Cannabis sativa, has been used for recreational and therapeutic purposes for a thousands of years. However, how marijuana modifies variety of brain functions was a long-standing mystery. In 1964, Δ9-tetrahydrocannabinol (Δ9-THC) was identified as the main psychoactive component of marijuana. The receptor for Δ9-THC was reported in 1990, and was termed cannabinoid CB1 receptor. The second cannabinoid receptor, CB2, was reported in 1993. Meanwhile, the endogenous ligands for CB1 and CB2 receptors (endocannabinoids) were sought and two lipid compounds, anandamide and 2-arachidonoylglycerol (2-AG), were identified in 1992 and 1995, respectively. However, physiological roles of the endocannabinoid system remained unclear until 2001 when Prof. Masanobu Kano’s group and two other laboratories discovered that endocannabinoids function as “retrograde messenger” at synapses. His group demonstrated that depolarization of postsynaptic neurons releases endocannabinoid that retrogradely acts on presynaptic CB1 receptor and suppresses neurotransmitter release. His group also found that activation of Gq/11-coupled receptors in postsynaptic neurons causes endocannabinoid-mediated retrograde suppression of neurotransmitter release. By 2010, Prof. Kano and colleagues identified key molecules that involved in these phenomena and elucidated their basic mechanisms (see the cover figure and pp. 235-250 in his review). His group demonstrated that the endocannabinoid 2-AG is released from postsynaptic neurons following a large Ca2+ elevation caused by activation of voltage-gated Ca2+ channels or NMDARs, strong activation of Gq/11-coupled receptors, or combined subthreshold Ca2+ elevation and weak Gq/11-coupled receptor activation. Since CB1 receptor is widely expressed in presynaptic terminals throughout the brain, Prof. Kano proposes that 2-AG-mediated retrograde suppression is a fundamental and ubiquitous mechanism for the regulation of neurotransmitter release, and that this form of synaptic modulation therefore influences variety of brain functions.
*The figure was modified from Fig. 2 in Ohno-Shosaku, T., Tanimura, A., Hashimotodani, Y. and Kano, M. (2012) The Neuroscientist 18, 119-132.

Masahiko Watanabe
Professor
Hokkaido University Graduate School of Medicine

↑Go to TOP